4.4 Article

CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis

Zhen Zhang et al.

DISEASE MARKERS (2017)

Article Oncology

Leptomeningeal metastasis: Clinical experience of 519 cases

Jae-Won Hyun et al.

EUROPEAN JOURNAL OF CANCER (2016)

Article Oncology

Central Nervous System Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines

Louis Burt Nabors et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)

Article Oncology

Ventriculolumbar Perfusion Chemotherapy for the Treatment of Leptomeningeal Carcinomatosis A Phase I Study With Pharmacokinetic Data

Ho-Shin Gwak et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)

Article Oncology

Survival of breast cancer patients with meningeal carcinomatosis

H. Gauthier et al.

ANNALS OF ONCOLOGY (2010)

Article

New Strategies in the Management of Leptomeningeal Metastases

Morris D. Groves

ARCHIVES OF NEUROLOGY (2010)

Review Oncology

Leptomeningeal metastasis

Marc C. Chamberlain

CURRENT OPINION IN ONCOLOGY (2010)

Review Chemistry, Analytical

Electrogenerated Chemiluminescence

Robert J. Forster et al.

ANNUAL REVIEW OF ANALYTICAL CHEMISTRY (2009)

Review Medical Laboratory Technology

Clinical utility of cytokeratins as tumor markers

V Barak et al.

CLINICAL BIOCHEMISTRY (2004)